FDA broadens use of Novartis’ radiopharma drug Pluvicto

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.

UNEP Annual Report: Global cooperation delivered environmental gains in 2025 – EnviroNews

February 12, 2026

Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay

Madrigal turns to RNAi drugs from China to bolster MASH pipeline

February 11, 2026

Source link

FDA broadens use of Novartis’ radiopharma drug Pluvicto

UNEP Annual Report: Global cooperation delivered environmental gains in 2025 – EnviroNews

Madrigal turns to RNAi drugs from China to bolster MASH pipeline

Banks Can Now Engage With Crypto Without Prior Approval

Taaleem maintains its growth trajectory in H1 2024/25

Taaleem maintains its growth trajectory in H1 2024/25

Leave a Reply Cancel reply

RECOMMENDED NEWS

Report warns tow-to-port costs could outweigh O&E by 2035

Defense One Radio, Ep. 156: The future of Taiwan’s security with Dmitri Alperovitch

New Report Reveals ISIS Conducts Over 60% of Global Activities in Africa, Signifying New Frontier for International Terrorism

African Multilateral Financial Institutions forge historic strategic alliance to serve as catalyst for Sustainable Economic Development and financial self-reliance in Africa

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

FDA broadens use of Novartis’ radiopharma drug Pluvicto

Related posts

Banks Can Now Engage With Crypto Without Prior Approval

Taaleem maintains its growth trajectory in H1 2024/25

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS